<DOC>
	<DOCNO>NCT01009580</DOCNO>
	<brief_summary>This trial conduct Asia , Europe Oceania . The aim clinical trial compare NN5401 ( insulin degludec/insulin aspart ) biphasic insulin aspart 30 subject type 2 diabetes .</brief_summary>
	<brief_title>Comparison NN5401 With Biphasic Insulin Aspart 30 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Dipeptidyl-Peptidase IV Inhibitors</mesh_term>
	<criteria>Type 2 diabetes mellitus ( diagnose clinically ) least 6 month Subjects premixed human analogue insulin selfmixed insulin regimen , contain 2040 % fast/rapidacting component , daily ( OD ) twice daily ( BID ) , without oral antidiabetic drug ) ( OADs ) ( metformin , sulphonylurea ( SU ) , glinides , alphaglucosidase inhibitor , DPP4 ( dipeptidyl peptidase4 ) inhibitor pioglitazone ) , least 3 month Visit 1 HbA1c 7.010.0 % ( inclusive ) central laboratory analysis Body Mass Index ( BMI ) equal 40.0 kg/m^2 Treatment insulin regimen list key inclusion criterion . 2 within 3 month Treatment rosiglitazone glucagonlike peptide1 ( GLP1 ) receptor agonist ( exenatide , liraglutide ) within 3 month prior visit 1 Cardiovascular disease within last 6 month prior visit 1 , define : stroke ; decompensated heart failure New York Heart Association ( NYHA ) class III IV ; myocardial infarction ; unstable angina pectoris ; coronary arterial bypass graft angioplasty Uncontrolled treated/untreated severe hypertension ( systolic blood pressure least 180 millimetre ( mm ) mercury ( Hg ) and/or diastolic blood pressure least 100 mmHg ) Pregnancy , breastfeeding , intention become pregnant use adequate contraceptive measure accord local requirement Cancer medical history cancer ( except basal cell skin cancer squamous cell skin cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>